Cargando…

Docking based 3D-QSAR studies applied at the BRAF inhibitors to understand the binding mechanism

Detalles Bibliográficos
Autores principales:	Mahmood, Uzma, ul-Haq, Zaheer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341267/ http://dx.doi.org/10.1186/1758-2946-4-S1-P46

Ejemplares similares

A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitors
por: Ul-Haq, Zaheer, et al.
Publicado: (2013)

Quantum mechanics and 3D-QSAR studies on thienopyridine analogues: inhibitors of IKKβ
por: Ul-Haq, Zaheer, et al.
Publicado: (2020)

Molecular docking simulation studies on potent butyrylcholinesterase inhibitors obtained from microbial transformation of dihydrotestosterone
por: Zafar, Salman, et al.
Publicado: (2013)

3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model
por: Ul-Haq, Zaheer, et al.
Publicado: (2016)

Automating QSAR expertise
por: Leahy, DE, et al.
Publicado: (2008)

Analysis of naphthoquinone derivatives as topoisomerase I inhibitors using fragment based QSAR
por: Virupaksha, Bastikar, et al.
Publicado: (2013)

QSAR of anti-inflammatory drugs
por: Khayrullina, Veronica R, et al.
Publicado: (2010)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

Surflex-QMOD: physically meaningful QSAR
por: Steudle, Alexander, et al.
Publicado: (2014)

Sodium dependent glucose transporter (SGLT) 1 / 2 - elucidating inhibitor SAR and selectivity using homology modelling and 3D QSAR studies
por: Vorberg, Susann, et al.
Publicado: (2012)

On some aspects of validation of predictive QSAR models
por: Roy, K, et al.
Publicado: (2008)

QSAR modelling of acute toxicity in the fathead minnow
por: Zakharov, Alexey, et al.
Publicado: (2008)

Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors
por: Ashraf, Noureen, et al.
Publicado: (2022)

Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach
por: Ashraf, Sajda, et al.
Publicado: (2021)

Kernel-based estimation of the applicability domain of QSAR models
por: Fechner, Nikolas, et al.
Publicado: (2010)

3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors
por: Fang, Yajing, et al.
Publicado: (2016)

3D-QSPR Method of Computational Technique Applied on Red Reactive Dyes by Using CoMFA Strategy
por: Mahmood, Uzma, et al.
Publicado: (2011)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Updating existing QSAR models: selection and weighting of new data
por: Öberg, Tomas, et al.
Publicado: (2010)

Diagnostic of tautomer behaviour on QSAR models and AM1 optimisation
por: Thalheim, T, et al.
Publicado: (2011)

Reliable estimation of externally validated prediction errors for QSAR models
por: Baumann, Désirée, et al.
Publicado: (2013)

A new software for fragment-based QSAR and its applications
por: Sosnin, Sergey B, et al.
Publicado: (2014)

Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors
por: Lu, Shuai, et al.
Publicado: (2011)

Postprocessing of molecular docking poses using binding free energy calculations
por: Wichapong, Kanin, et al.
Publicado: (2012)

Quantum-mechanics-based molecular interaction fields for 3D-QSAR
por: ElKerdawy, Ahmed, et al.
Publicado: (2014)

Prediction of highly-connected 'hub'-proteins in protein interaction networks using QSAR
por: Hsing, M, et al.
Publicado: (2010)

QSPR designer – employ your own descriptors in the automated QSAR modeling process
por: Skřehota, Ondřej, et al.
Publicado: (2012)

2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors
por: Zhao, Manman, et al.
Publicado: (2017)

Docking and virtual screening of novel inhibitors for mono-ADP-ribosylating toxins
por: Scharfe, M, et al.
Publicado: (2011)

3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
por: Wang, Yuwei, et al.
Publicado: (2021)

Automatic docking of a small number of ligands into a large number of binding sites
por: Kos, Alexander
Publicado: (2013)

Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results
por: Kefford, Richard, et al.
Publicado: (2014)

QSAR modeling for In vitro assays: linking ToxCast™ database to the integrated modeling framework “OCHEM”
por: Abdelaziz, Ahmed, et al.
Publicado: (2012)

Building QSAR for HTS in vitro assays - a study for the prediction of Aryl hydrocarbon receptor activators
por: Abdelaziz, Ahmed M, et al.
Publicado: (2013)

Comparison of applicability domains of QSAR models: application to the modelling of the environmental toxicity against Tetrahymena pyriformis
por: Tetko, Igor V, et al.
Publicado: (2008)

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
por: Ascierto, Paolo Antonio, et al.
Publicado: (2013)

Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
por: Tian, Yuanxin, et al.
Publicado: (2011)

3D-QSAR, Molecular Docking and Molecular Dynamics Simulation of Pseudomonas aeruginosa LpxC Inhibitors
por: Zuo, Ke, et al.
Publicado: (2017)

2D-QSAR and docking study of a series of coumarin derivatives as inhibitors of CDK (anticancer activity) with an application of the molecular docking method
por: Kasmi, Rania, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7k6lvj3ialkk7vr25d6gnukr7e